Last reviewed · How we verify
Fuji IX EXTRA
Fuji IX EXTRA's mechanism is not publicly available.
Fuji IX EXTRA's mechanism is not publicly available. Used for Phase 3 clinical trials for Fuji IX EXTRA are ongoing, but specific indications are not publicly available..
At a glance
| Generic name | Fuji IX EXTRA |
|---|---|
| Also known as | Extra fast GIC |
| Sponsor | Marina F Fahmy, MD |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available about the exact mechanism of action of Fuji IX EXTRA.
Approved indications
- Phase 3 clinical trials for Fuji IX EXTRA are ongoing, but specific indications are not publicly available.
Common side effects
- Unknown
Key clinical trials
- Clinical Evaluation of Bioactive Resin Composites Versus Caries Control Technique in Management of Class I Carious Cavities in High Caries Risk Patients: a Randomized Clinical Trial (NA)
- Fluoride Release,Compressive Strength and Clinical Performance of a Bioactive Restorative Material in ART (PHASE3)
- A Clinical Trial to Assess the Retention and Caries Preventive Effect of Resin Based Sealants Versus ART Sealants (PHASE2, PHASE3)
- Influence of Luting Cement on the Clinical Outcomes of Zirconia Pediatric Crowns (NA)
- High-strength Glass-ionomer Dental Restorations (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fuji IX EXTRA CI brief — competitive landscape report
- Fuji IX EXTRA updates RSS · CI watch RSS
- Marina F Fahmy, MD portfolio CI